McConkey DJ - Search Results

1

Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.

Kassouf W, Dinney CP, Brown G, McConkey DJ, Diehl AJ, Bar-Eli M, Adam L. Kassouf W, et al. Among authors: mcconkey dj. Cancer Res. 2005 Nov 15;65(22):10524-35. doi: 10.1158/0008-5472.CAN-05-1536. Cancer Res. 2005. PMID: 16288045

2

Increased apoptosis in metastatic human colonic adenocarcinomas.

Termuhlen PM, Sweeney-Gotsch BM, Berman RS, Ellis LM, Bucana C, Shen Y, Cleary KR, McConkey DJ. Termuhlen PM, et al. Among authors: mcconkey dj. Cancer Biol Ther. 2002 Jan-Feb;1(1):58-63. doi: 10.4161/cbt.1.1.43. Cancer Biol Ther. 2002. PMID: 12170764 Free article.

3

Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.

Pahler JC, Ruiz S, Niemer I, Calvert LR, Andreeff M, Keating M, Faderl S, McConkey DJ. Pahler JC, et al. Among authors: mcconkey dj. Clin Cancer Res. 2003 Oct 1;9(12):4570-7. Clin Cancer Res. 2003. PMID: 14555532

4

Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts.

Williams S, Pettaway C, Song R, Papandreou C, Logothetis C, McConkey DJ. Williams S, et al. Among authors: mcconkey dj. Mol Cancer Ther. 2003 Sep;2(9):835-43. Mol Cancer Ther. 2003. PMID: 14555702

5

The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells.

Williams SA, McConkey DJ. Williams SA, et al. Among authors: mcconkey dj. Cancer Res. 2003 Nov 1;63(21):7338-44. Cancer Res. 2003. PMID: 14612532

6

Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors.

Davis DW, Shen Y, Mullani NA, Wen S, Herbst RS, O'Reilly M, Abbruzzese JL, McConkey DJ. Davis DW, et al. Among authors: mcconkey dj. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):33-42. doi: 10.1158/1078-0432.ccr-0736-3. Clin Cancer Res. 2004. PMID: 14734449

7

The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts.

Nawrocki ST, Sweeney-Gotsch B, Takamori R, McConkey DJ. Nawrocki ST, et al. Among authors: mcconkey dj. Mol Cancer Ther. 2004 Jan;3(1):59-70. Mol Cancer Ther. 2004. PMID: 14749476

8

The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo.

Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, Millikan R, Shen Y, Dinney CP, McConkey DJ. Kamat AM, et al. Among authors: mcconkey dj. Mol Cancer Ther. 2004 Mar;3(3):279-90. Mol Cancer Ther. 2004. PMID: 15026548

9

Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors.

Zheng B, Georgakis GV, Li Y, Bharti A, McConkey D, Aggarwal BB, Younes A. Zheng B, et al. Clin Cancer Res. 2004 May 1;10(9):3207-15. doi: 10.1158/1078-0432.ccr-03-0494. Clin Cancer Res. 2004. PMID: 15131062

10

Direct effects of recombinant human endostatin on tumor cell IL-8 production are associated with increased endothelial cell apoptosis in an orthotopic model of human pancreatic cancer.

Raut CP, Takamori RK, Davis DW, Sweeney-Gotsch B, O'Reilly MS, McConkey DJ. Raut CP, et al. Among authors: mcconkey dj. Cancer Biol Ther. 2004 Jul;3(7):679-87. doi: 10.4161/cbt.3.7.967. Epub 2004 Jul 10. Cancer Biol Ther. 2004. PMID: 15197351 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters